DOI: 10.1128/CMR.00071-17
Article Information
PubMed
Published By
History
- Published online November 29, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology. All Rights Reserved.
Author Information
- Hamed Haddad Kashania,
- Mathias Schmelcherb,
- Hamed Sabzalipoorc,
- Elahe Seyed Hosseinia and
- Rezvan Moniria,d
- aAnatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, Iran
- bInstitute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland
- cDepartment of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran
- dDepartment of Immunology and Microbiology, Kashan University of Medical Sciences, Kashan, Iran
- Address correspondence to Mathias Schmelcher, mathias.schmelcher{at}hest.ethz.ch, or Rezvan Moniri, hamedir2010{at}gmail.com.
Citation Haddad Kashani H, Schmelcher M, Sabzalipoor H, Seyed Hosseini E, Moniri R. 2018. Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: current status of research and novel delivery strategies. Clin Microbiol Rev 31:e00071-17. https://doi.org/10.1128/CMR.00071-17.
